Long-Term Engagement and Motivation Through Innovative Strategies in Adapted Physical Activity (IMPULSION)

May 12, 2026 updated by: Centre Hospitalier Universitaire de Nice

IMPULSION: Long-Term Engagement and Motivation Through Innovative Strategies in Adapted Physical Activity

Aging is associated with progressive declines in physical, functional, and psychosocial capacities, leading to reduced autonomy, increased risk of falls, chronic diseases, and decreased quality of life. Physical inactivity is a major aggravating factor, despite strong evidence that regular physical activity helps prevent age-related decline.

Adapted Physical Activity (APA) has demonstrated beneficial effects on physical function, mental health, pain, and healthcare utilization. However, long-term adherence to APA programs among older adults remains low, with fewer than 20% meeting World Health Organization recommendations. Therefore, innovative strategies are needed to improve sustained engagement in physical activity.

This multicenter, randomized, single-blind interventional study aims to compare the effectiveness of different APA strategies on long-term engagement in physical activity among adults aged 60 years and older.

A total of 600 participants will be randomized into four groups combining two key factors: (1) autonomy-based vs. non-autonomy-based approaches, and (2) classical APA vs. TEMPA-based APA programs. Each intervention consists of a 12-week program including 24 supervised sessions, with some groups incorporating a progressive transition toward autonomous practice.

The primary outcome is long-term physical activity engagement assessed using the QAPPA questionnaire at baseline, 6 months, and 12 months.

Secondary outcomes include:

Objective and self-reported physical activity levels (questionnaires and wearable devices) Functional capacities (muscle strength, endurance, gait speed, balance, cardiorespiratory fitness) Motivational and perceptual factors (e.g., enjoyment, fatigue, perceived effort, motivation) Quality of life (EQ-5D-5L) Biological markers (inflammatory, metabolic, metabolomic, and epigenetic profiles) to identify predictors of adherence and physiological response Cost-effectiveness and cost-utility analyses (incremental cost-effectiveness ratio)

Statistical analyses will be conducted using mixed linear models for repeated measures to evaluate time, group, and interaction effects. Additional analyses will include descriptive statistics, group comparisons, longitudinal trends, and economic evaluations.

This study aims to identify effective and sustainable APA strategies to improve long-term physical activity engagement and inform public health policies for older adults.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

600

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Nice, France
        • CHU de Nice - Hôpital de Cimiez
        • Contact:
        • Contact:
        • Principal Investigator:
          • OLIVIER GUERIN, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 60 or older
  • Affiliation with, or beneficiary of, a social security system
  • No objection to the study

Exclusion Criteria:

  • Neurocognitive disorder preventing the provision of informed consent (MOCA <18)
  • Individuals under legal protection
  • Individuals deprived of liberty
  • Presence of a physical or cognitive condition preventing participation in the adapted physical activity protocol over 3 months:
  • Neurocognitive disorder (MOCA <18)
  • Neurodegenerative disease with severe symptoms preventing participation in the protocol
  • Neuromuscular disease with severe symptoms preventing participation in the protocol
  • Severe sensory impairments (blindness or profound deafness)
  • Amputation of one or more limbs
  • Non-independent mobility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group A
autonomy arm and classical practice
Other: Group A autonomy arm and classical practice
All participants in Group A will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 15-week period. Two sessions per week will be provided during the first 9 weeks. From week 10 to week 15, only one supervised in-person session per week will be offered, and participants will be asked to complete the second session independently. This transition in session planning is expected to promote more sustainable long-term engagement in physical activity, Each session will consist of a warm-up (approximately 10-15 minutes), a main exercise phase (including endurance, strength, balance, flexibility, and coordination exercises), and a cool-down period. The structure of the sessions will be consistent and will comply with physical activity prescription guidelines for older adults
Experimental: group B
autonomy arm and TEMPA practice
Other: GROUP B autonomy arm and TEMPA practice

In Group B, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging focus on perceived enjoyment during exercise, allowing participants to choose music, involving participants in leading warm-ups, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions.

To ensure proper implementation, the instructor will receive specific training in the TEMPA theoretical model and its associated adaptations. The instructor will also be required to explicitly communicate the strategies used during sessions. A report documenting the strategies implemented will be completed by the instructor after each session
Experimental: group C
non-autonomy arm and classical practice
Other: Group C non-autonomy arm and classical practice
All participants in Group C will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 12-week period. Participants will attend two APA sessions per week.
Experimental: group D
non-autonomy arm and TEMPA practice
Other: Group D non-autonomy arm and TEMPA practice
In Group D, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging participants to focus on perceived enjoyment during exercise, allowing them to choose music, involving them in leading the warm-up, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effectiveness of different Adapted Physical Activity (APA) programs
Time Frame: at 12 months

The primary objective of this study is to compare the effectiveness of different Adapted Physical Activity (APA) programs on long-term engagement in physical activity among older adults.

Long-term engagement will be assessed through the level of physical activity, measured using the QAPPA questionnaire The Physical Activity Questionnaire for Older Adults (QAPPA) is a tool for measuring the physical activity of people aged 60 and over. It was developed to meet the objective of assessing the level of physical activity of older adults, taking into account their age and health.
at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analyze functional outcomes: strength
Time Frame: at 3 months, and 6 months and 12 months
Strength: time to complete the Five Sit-to-Stand test
at 3 months, and 6 months and 12 months
perceptual and motivational factors of engagement
Time Frame: at base line and at 3 months
EMAPS questionnaires: The Motivation Scale for Physical Activity for Health Purposes (EMAPS) is a tool that assesses individuals' motivations and engagement in physical activity. It measures intrinsic and extrinsic motivation, based on 7 main constructs: achievement, knowledge and stimulation, external, introjected and identified regulations, and amotivation. The scale includes 28 statements, each measured on a 1 to 7-point scale, thus allowing a precise assessment of participants' motivations.
at base line and at 3 months
perceptual and motivational factors of engagement
Time Frame: at base line and at 3 months
PES questionnaire: The Physical Effort Scale (PES) is a tool designed to measure the approach and avoidance tendencies towards physical effort. It is used to understand the engagement in physical activity. The scale consists of two factors: approach and avoidance, with each factor having a high internal consistency. The PES-FR has been shown to be valid for measuring individual differences in physical effort evaluation and has implications for promoting physical activity.
at base line and at 3 months
perceptual and motivational factors of engagement
Time Frame: at baseline and at 3 months
PANES questionnaire: PANES is a 17-item, self-administered questionnaire that assesses environmental factors in physical activity participation, such as neighborhood safety, aesthetic qualities, neighborhood infrastructure, and access to destinations
at baseline and at 3 months
Analyze functional outcomes: Muscular endurance
Time Frame: at 3 months, and 6 months and 12 months
Muscular endurance: time to complete the One-Minute Sit-to-Stand test
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Gait analysis
Time Frame: at 3 months, and 6 months and 12 months
Gait analysis: walking speed over 10 meters
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Balance
Time Frame: at 3 months, and 6 months and 12 months
Balance: stabilometric measurements
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Body composition
Time Frame: at 3 months, and 6 months and 12 months
Body composition: bioelectrical impedance analysis
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Cardiorespiratory endurance
Time Frame: at 3 months, and 6 months and 12 months
Cardiorespiratory endurance: VO₂ max and Harvard index assessed via the Harvard Step Test
at 3 months, and 6 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Nice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2031

Study Completion (Estimated)

September 1, 2031

Study Registration Dates

First Submitted

May 5, 2026

First Submitted That Met QC Criteria

May 12, 2026

First Posted (Actual)

May 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 25-PP-27

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Group A autonomy arm and classical practice

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe